Viewbix Inc. has signed a definitive agreement to acquire up to 100% (and not less than 85%) of Quantum X Labs, including its expanding patent portfolio and prior intellectual property in quantum error correction. The acquisition is expected to close within 90 days of the agreement's execution on December 15, 2025, pending final due diligence, regulatory approvals, and customary closing conditions. Quantum X Labs recently achieved a significant milestone with the filing of a provisional patent for technology that uses quantum computing to enhance Markov Chain Monte Carlo methods, potentially transforming clinical trial data analysis and advancing personalized medicine in the pharmaceutical industry.